This chapter discusses the criteria for participants in studies on PTSD, the use of MDMA for deeper therapeutic work, the treatment protocol for using MDMA in therapy, the findings of a study comparing the effects of MDMA therapy versus a placebo on individuals with PTSD, and the ongoing phase three trial of MDMA therapy for PTSD.
Major trials are bringing us a step closer to seeing psychedelic substances used in therapy practice for PTSD, anxiety and depression. On this episode of All in the Mind, we take a look at where the research is currently at.